Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes is a type of aggressive non-Hodgkin lymphoma characterized by the proliferation of immature lymphoid cells. This condition primarily affects the intra-abdominal lymph nodes and can lead to significant morbidity if not diagnosed and treated promptly. The ICD-10 Code C83.53 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this serious condition.
What is ICD-10 Code C83.53 for Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes?
ICD-10 Code C83.53 represents Lymphoblastic (diffuse) lymphoma affecting the intra-abdominal lymph nodes. This aggressive lymphoma is characterized by the presence of immature lymphocytes and can lead to severe complications if untreated. The code should be used in clinical documentation and billing when a patient is diagnosed with this specific type of lymphoma, ensuring proper coding for treatment and management.
ICD-10 Code C83.53 – Clinical Definition and Explanation of Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes
Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes is a hematological malignancy that arises from immature lymphoid cells, often presenting in the abdominal region. It is crucial to recognize this condition early due to its aggressive nature and potential for rapid progression. Prompt medical intervention is necessary to improve patient outcomes.
Key Clinical Features:
- Commonly presents with abdominal pain and swelling due to lymphadenopathy.
- May cause systemic symptoms such as fever, night sweats, and weight loss.
- Often diagnosed in children and young adults, with a higher prevalence in males.
- Can lead to complications such as bowel obstruction or perforation.
ICD-10 Code C83.53 for Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes – SOAP Notes & Clinical Use
ICD-10 Code C83.53 is utilized in SOAP notes to document the diagnosis and management of Lymphoblastic (diffuse) lymphoma affecting intra-abdominal lymph nodes. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
What Does ICD-10 Code C83.53 for Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.53 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Lymphoblastic (diffuse) lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C83.53 – Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes
The management of Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes requires urgent medical intervention, often necessitating hospitalization for intensive treatment.
Antibiotic Therapy:
- Not applicable as this condition is not infectious; treatment focuses on chemotherapy.
- Common regimens include multi-agent chemotherapy protocols.
Supportive Care:
- Management of symptoms such as pain and nausea.
- Nutritional support and hydration.
- Monitoring for complications such as infection or tumor lysis syndrome.
Infection Control:
- Standard precautions to prevent infection during chemotherapy.
- Isolation may be necessary for immunocompromised patients.
How to Document Symptoms of Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes (ICD-10 C83.53) in SOAP Notes
Subjective:
- Patient reports abdominal pain and swelling.
- History of unexplained weight loss over the past month.
- Complaints of night sweats and fatigue.
- No prior history of lymphoma or significant medical conditions.
Objective:
- Abdominal examination reveals palpable lymphadenopathy.
- Vital signs: elevated temperature (100.5°F), normal blood pressure.
- Laboratory tests show elevated white blood cell count.
- Imaging studies indicate enlarged intra-abdominal lymph nodes.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes (ICD-10 Code C83.53)
Assessment:
- Diagnosis: Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes, severe.
- ICD-10 Code: C83.53.
- Contributing factors: age, gender, and presenting symptoms.
- Consideration of differential diagnoses such as other lymphomas or infections.
Plan:
- Initiate chemotherapy regimen as per oncology guidelines.
- Provide education on potential side effects and symptom management.
- Schedule regular follow-up appointments for monitoring treatment response.
- Consider referral to a specialist for further evaluation and management.
Treatment & Plan Section for ICD-10 Code C83.53 – Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes
- First-line pharmacologic treatments include multi-agent chemotherapy regimens.
- Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
- Monitoring practices include regular imaging and laboratory tests to assess treatment response.
- Follow-up appointments should be scheduled every 1-3 months during active treatment.
Using ICD-10 Code C83.53 for Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes in Billing & SOAP Note Compliance
- Select accurate subcodes based on clinical severity or complications.
- Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
- Ensure treatment plans align with clinical guidelines to support justified billing.
- Only list CPT codes that are commonly billed with ICD-10 Code C83.53 based on standard medical coding practices.
Related ICD-10 Codes Often Used with Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes
- C83.50 – Lymphoblastic lymphoma, unspecified site
- C83.51 – Lymphoblastic lymphoma, lymph nodes of head, face, and neck
- C83.52 – Lymphoblastic lymphoma, lymph nodes of axilla and upper limb
- C83.54 – Lymphoblastic lymphoma, lymph nodes of mediastinum
ICD-10 Code C83.53 in Medical Billing and Insurance for Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes
ICD-10 Code C83.53 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
Billing Notes:
- Ensure accurate documentation of the diagnosis and treatment plan to support claims.
- Use this code in conjunction with appropriate CPT codes for chemotherapy administration.
- Document all relevant clinical findings and patient history to justify the use of this code.
- Review payer-specific guidelines for coding and billing practices.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with differential. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.53 for Lymphoblastic (diffuse) lymphoma, intra-abd lymph nodes
What are the common symptoms of Lymphoblastic lymphoma?
Common symptoms include abdominal pain, swelling, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and lymphadenopathy.
How is Lymphoblastic lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of immature lymphoid cells.
What is the treatment for Lymphoblastic lymphoma?
Treatment usually involves aggressive chemotherapy regimens tailored to the patient's specific condition, often requiring hospitalization for monitoring and supportive care.
Is Lymphoblastic lymphoma contagious?
No, Lymphoblastic lymphoma is not contagious. It is a type of cancer that arises from genetic mutations in lymphoid cells and cannot be transmitted from person to person.
